Rise Therapeutics Llc

This early-stage study is testing the safety of an oral probiotic called R-3750 in people with mild to moderate COPD. The 27 participants will take the probiotic and report on their symptoms and quality of life. Researchers will also check blood and stool samples to see if the pr…

This is an early safety study to see if a new oral probiotic called R-2487 is safe and well-tolerated in people with Sjogren's Syndrome. The study will enroll 36 participants who will take the probiotic, and doctors will check for side effects, measure inflammation, and see if it…